ENCODE cell lines, expression (Ernst 2011)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
SP1 | hg19_v2_chr12_+_53774423_53774658 | -0.62 | 1.1e-02 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_-_149688655 | 6.65 |
ENST00000461930.1 ENST00000423691.2 ENST00000490975.1 ENST00000461868.1 ENST00000452853.2 |
PFN2 |
profilin 2 |
chr19_-_50143452 | 6.58 |
ENST00000246792.3 |
RRAS |
related RAS viral (r-ras) oncogene homolog |
chr9_-_35691017 | 5.99 |
ENST00000378292.3 |
TPM2 |
tropomyosin 2 (beta) |
chr10_-_126849588 | 5.80 |
ENST00000411419.2 |
CTBP2 |
C-terminal binding protein 2 |
chr2_+_30369859 | 5.75 |
ENST00000402003.3 |
YPEL5 |
yippee-like 5 (Drosophila) |
chr17_-_1619535 | 5.72 |
ENST00000573075.1 ENST00000574306.1 |
MIR22HG |
MIR22 host gene (non-protein coding) |
chr19_+_41725088 | 5.57 |
ENST00000301178.4 |
AXL |
AXL receptor tyrosine kinase |
chr17_-_1619491 | 5.38 |
ENST00000570416.1 ENST00000575626.1 ENST00000610106.1 ENST00000608198.1 ENST00000609442.1 ENST00000334146.3 ENST00000576489.1 ENST00000608245.1 ENST00000609398.1 ENST00000608913.1 ENST00000574016.1 ENST00000571091.1 ENST00000573127.1 ENST00000609990.1 ENST00000576749.1 |
MIR22HG |
MIR22 host gene (non-protein coding) |
chr2_+_30369807 | 5.04 |
ENST00000379520.3 ENST00000379519.3 ENST00000261353.4 |
YPEL5 |
yippee-like 5 (Drosophila) |
chr3_-_149688502 | 5.00 |
ENST00000481767.1 ENST00000475518.1 |
PFN2 |
profilin 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 35.1 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.5 | 23.8 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.6 | 21.9 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.3 | 19.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.6 | 19.3 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 16.7 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.6 | 16.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.5 | 13.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.4 | 13.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.3 | 12.7 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 18.5 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.2 | 12.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 7.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 6.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.3 | 6.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 6.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.3 | 5.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 5.2 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.2 | 4.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 3.9 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 15.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 12.5 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.2 | 11.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.4 | 10.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 9.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 8.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 7.4 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 7.3 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 7.3 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.2 | 5.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 5.1 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.0 | 4.2 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 3.5 | GO:0045121 | membrane raft(GO:0045121) |
0.0 | 3.2 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.1 | 2.9 | GO:0002102 | podosome(GO:0002102) |
0.2 | 2.5 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 2.2 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 2.0 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 2.0 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 1.9 | GO:0045171 | intercellular bridge(GO:0045171) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 22.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.8 | 16.6 | GO:0000052 | citrulline metabolic process(GO:0000052) |
1.3 | 15.4 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.8 | 12.5 | GO:0051639 | actin filament network formation(GO:0051639) |
1.5 | 12.0 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.2 | 11.8 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.2 | 11.6 | GO:1901016 | regulation of potassium ion transmembrane transporter activity(GO:1901016) |
1.4 | 11.3 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.4 | 10.9 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
1.5 | 10.7 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 15.5 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 9.4 | GO:0043195 | terminal bouton(GO:0043195) |
0.2 | 7.7 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 7.7 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 7.5 | GO:0002102 | podosome(GO:0002102) |
0.6 | 6.9 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 6.6 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 6.4 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 6.2 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
1.9 | 5.7 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 5.8 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 5.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
1.4 | 4.3 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.1 | 3.9 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 3.4 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 2.9 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 2.7 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 2.6 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.1 | 2.5 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 2.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 64.9 | GO:0005925 | focal adhesion(GO:0005925) |
0.2 | 44.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 32.7 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.3 | 29.4 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.2 | 28.9 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.3 | 28.0 | GO:0005604 | basement membrane(GO:0005604) |
1.2 | 23.0 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.2 | 20.1 | GO:0032432 | actin filament bundle(GO:0032432) |
0.2 | 18.5 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 16.2 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 5.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 4.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 3.4 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 2.5 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 2.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 1.4 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 1.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 1.4 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 1.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 1.1 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 48.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 36.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.4 | 25.5 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.4 | 23.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.4 | 22.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.5 | 16.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 15.4 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 13.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.6 | 12.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 12.1 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 40.5 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 34.5 | GO:0045296 | cadherin binding(GO:0045296) |
0.9 | 34.1 | GO:0043236 | laminin binding(GO:0043236) |
0.1 | 23.4 | GO:0003779 | actin binding(GO:0003779) |
0.2 | 22.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.6 | 22.0 | GO:0003785 | actin monomer binding(GO:0003785) |
0.3 | 21.1 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.4 | 14.4 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 14.3 | GO:0044325 | ion channel binding(GO:0044325) |
0.2 | 13.0 | GO:0005518 | collagen binding(GO:0005518) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 6.1 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.6 | 5.1 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.6 | 3.9 | GO:0051414 | response to cortisol(GO:0051414) |
0.2 | 3.9 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.1 | 3.4 | GO:0003334 | keratinocyte development(GO:0003334) |
0.4 | 3.0 | GO:0032596 | protein transport within lipid bilayer(GO:0032594) protein transport into membrane raft(GO:0032596) |
0.2 | 2.7 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.4 | 2.6 | GO:1902957 | negative regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902957) |
0.2 | 2.5 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
0.6 | 2.2 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 6.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.3 | 5.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 3.1 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 2.5 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 2.0 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 1.7 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.2 | 1.6 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 1.4 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 1.4 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 1.3 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.2 | 15.5 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.2 | 14.8 | GO:0008307 | structural constituent of muscle(GO:0008307) |
2.6 | 10.5 | GO:0004598 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
0.2 | 8.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 7.9 | GO:0008201 | heparin binding(GO:0008201) |
0.2 | 7.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 7.5 | GO:0005178 | integrin binding(GO:0005178) |
0.3 | 7.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
1.2 | 6.2 | GO:0016403 | dimethylargininase activity(GO:0016403) |
1.5 | 5.9 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.2 | 15.5 | GO:1900085 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
0.5 | 15.2 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.9 | 10.9 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
2.6 | 10.5 | GO:0001519 | peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
0.0 | 8.2 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.7 | 7.8 | GO:0009414 | response to water deprivation(GO:0009414) |
0.5 | 7.6 | GO:0035878 | nail development(GO:0035878) |
0.4 | 6.2 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.8 | 5.9 | GO:0046836 | glycolipid transport(GO:0046836) |
0.3 | 5.9 | GO:0003334 | keratinocyte development(GO:0003334) |